Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features to both the delivery system and implant
Medtronic has announced the launch of CE marked fourth-generation flow diverter, Pipeline Vantage with Shield Technology for endovascular treatment of brain aneurysms.
Pipeline Vantage with Shield Technology is a new flow diverter with enhanced design features to both the delivery system and implant. These features allow physicians to deliver, deploy and treat brain aneurysms, intracranial aneurysms with greater ease and reliability while providing a scaffold that promotes growth of cells in the inner lining of the target blood vessel.
Medtronic is also introducing a warranty program called the PED Warranty Program. Through the warranty program, patients treated with Medtronic’s Pipeline Embolization Device (Pipeline Flex Embolization Device with Shield Technology/ Pipeline Vantage with Shield Technology) will receive a warranty coverage.
Flow diversion therapy has lesser chances of reestablishment of blood flow into the occluded aneurysm than other modalities with comparable acute morbidity and mortality rates. Medtronic’s fourth-generation PED Pipeline Vantage Embolization Device with Shield Technology has been designed keeping in mind the strong clinical evidence for flow diverters as a mode of treatment for aneurysms.
- Advertisement -